Medicare could save up to 74% of the money lost from discarded Alzheimer's drug lecanemab by the simple introduction of a new vial size that would reduce the amount of unused medication that is thrown away. As it is, nearly 6% of the medication is discarded, costing Medicare $1,600 per patient per year.
